Role of the Oral Microbiome in Blood Pressure Regulation in Pregnancy
NCT ID: NCT03930693
Last Updated: 2024-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2019-06-06
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Inorganic nitrate is a compound found in certain types of food, particularly green leafy vegetables and beetroot. Nitrate provides an important source of nitric oxide (NO), a molecule involved in keeping blood vessels healthy and regulating blood pressure. Supplementation with nitrate in the diet, using interventions such as beetroot juice, has been shown to reduce blood pressure and improve blood vessel function.
In order for dietary nitrate to have these beneficial effects, it needs to be converted in the body to nitrite, via bacteria that live in the mouth (oral bacteria). Differences in oral bacteria, and how they metabolise nitrate, are thought to influence blood pressure regulation and potentially response to dietary nitrate supplementation.
This study aims to understand (1) whether pregnant women with high blood pressure have a different composition of oral bacteria compared to healthy pregnant women and women who are not pregnant, and (2) how differences in oral bacteria affect blood pressure responses to a dose of dietary nitrate (in the form of beetroot juice).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Dietary Nitrate in Hypertensive Pregnant Women
NCT02520687
The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy
NCT04604535
Effects of Nitrate-rich Beetroot Juice in Pregnant Women With High Blood Pressure
NCT05241327
Acute Beetroot Juice Supplementation in Pre-eclampsia Pregnancies
NCT06387784
Pregnancy, Nitrate, Endothelial Function and Tissue Oxygen Saturation
NCT03315806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normotensive pregnant women
Normotensive pregnant women
Beetroot juice
Beetroot juice shot (70mL containing 400mg inorganic nitrate)
Hypertensive pregnant women
Hypertensive pregnant women
Beetroot juice
Beetroot juice shot (70mL containing 400mg inorganic nitrate)
Normotensive non-pregnant women
Normotensive non-pregnant women
Beetroot juice
Beetroot juice shot (70mL containing 400mg inorganic nitrate)
Hypertensive non-pregnant women
Hypertensive non-pregnant women
Beetroot juice
Beetroot juice shot (70mL containing 400mg inorganic nitrate)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beetroot juice
Beetroot juice shot (70mL containing 400mg inorganic nitrate)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For pregnant women, between 20-28 weeks gestation
Exclusion Criteria
* Age under 16, or over 45 years of age
* Lacking ability to consent
* Pre-existing diabetes (Type 1/Type 2)
* Previous history of pre-term FGR (delivery before 32 weeks with FGR)
* Current tobacco smoker
* Body Mass Index greater than or equal to 40 or less than or equal to 18
* Use of any of the following drugs in the last 6 months: systemic antibiotics, antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral)
* Large doses of commercial probiotics (greater than or equal to 108 cfu or organisms per day) including tablets, capsules, lozenges, chewing gum or powders (ordinary dietary components such as yoghurts do not apply)
* Evidence of oral disease, assessed on screening proforma (current conditions of: oral candidiasis (thrush); Dental caries (tooth decay); Halitosis; Oral ulcerations/mouth ulcers; Wisdom tooth pain; Chronic dry mouth)
* Allergy to beetroot juice or lemon juice (both contained within the juice shot)
16 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Jenny Myers
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jenny Myers, BM, PhD
Role: PRINCIPAL_INVESTIGATOR
Manchester University NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maternal and Fetal Health Research Centre, St Mary's Hospital
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Willmott T, Ormesher L, McBain AJ, Humphreys GJ, Myers JE, Singh G, Lundberg JO, Weitzberg E, Nihlen C, Cottrell EC. Altered Oral Nitrate Reduction and Bacterial Profiles in Hypertensive Women Predict Blood Pressure Lowering Following Acute Dietary Nitrate Supplementation. Hypertension. 2023 Nov;80(11):2397-2406. doi: 10.1161/HYPERTENSIONAHA.123.21263. Epub 2023 Sep 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
246813
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.